2017 Q1 Form 10-K Financial Statement
#000114420417032547 Filed on June 14, 2017
Income Statement
| Concept | 2017 Q1 | 2017 | 2016 Q1 |
|---|---|---|---|
| Revenue | $1.350M | $7.327M | $5.195M |
| YoY Change | -74.01% | -41.38% | 320.99% |
| Cost Of Revenue | $172.0K | $5.898M | $1.036M |
| YoY Change | -83.4% | 31.54% | 14.6% |
| Gross Profit | $1.178M | $3.739M | $4.159M |
| YoY Change | -71.68% | -53.34% | 1156.5% |
| Gross Profit Margin | 87.26% | 51.03% | 80.06% |
| Selling, General & Admin | $2.441M | ||
| YoY Change | -24.57% | ||
| % of Gross Profit | 65.28% | ||
| Research & Development | $8.302M | ||
| YoY Change | -33.21% | ||
| % of Gross Profit | 222.01% | ||
| Depreciation & Amortization | $210.0K | $714.5K | $180.0K |
| YoY Change | 16.67% | 7.21% | -357.14% |
| % of Gross Profit | 17.83% | 19.11% | 4.33% |
| Operating Expenses | $4.368M | $11.10M | $3.588M |
| YoY Change | 21.74% | -32.06% | -38.01% |
| Operating Profit | -$3.190M | -$7.356M | $571.0K |
| YoY Change | -658.67% | -11.55% | -110.46% |
| Interest Expense | $238.2K | ||
| YoY Change | -15.12% | ||
| % of Operating Profit | |||
| Other Income/Expense, Net | $4.000K | $9.300M | $7.408M |
| YoY Change | -99.95% | 30.73% | -924.94% |
| Pretax Income | $1.944M | ||
| YoY Change | -261.5% | ||
| Income Tax | $0.00 | -$1.868M | -$520.0K |
| % Of Pretax Income | -96.09% | ||
| Net Earnings | -$3.186M | $3.811M | $8.499M |
| YoY Change | -137.49% | -658.0% | -233.84% |
| Net Earnings / Revenue | -236.0% | 52.02% | 163.6% |
| Basic Earnings Per Share | $0.03 | $0.03 | $0.03 |
| Diluted Earnings Per Share | -$0.01 | -$0.01 | $0.00 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 838.7M shares | 695.2M shares | |
| Diluted Shares Outstanding | 844.5M shares |
Balance Sheet
| Concept | 2017 Q1 | 2017 | 2016 Q1 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $10.59M | $10.59M | $11.51M |
| YoY Change | -7.99% | -7.97% | 54.29% |
| Cash & Equivalents | $10.98M | $11.51M | |
| Short-Term Investments | |||
| Other Short-Term Assets | $470.0K | $468.0K | $380.0K |
| YoY Change | 23.68% | 23.89% | -2.56% |
| Inventory | $6.420M | $6.416M | $3.294M |
| Prepaid Expenses | |||
| Receivables | $930.0K | $934.1K | $1.530M |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $18.41M | $18.41M | $16.71M |
| YoY Change | 10.15% | 10.16% | 35.55% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $9.039M | $9.039M | $8.111M |
| YoY Change | 11.45% | 11.45% | 26.69% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | $6.419M | $6.412M | |
| YoY Change | 0.11% | 0.47% | |
| Long-Term Investments | $50.00K | $50.85K | $50.00K |
| YoY Change | 0.0% | 4.39% | -75.0% |
| Other Assets | $390.0K | $389.1K | $437.7K |
| YoY Change | -10.89% | 0.03% | -45.7% |
| Total Long-Term Assets | $15.90M | $15.90M | $14.96M |
| YoY Change | 6.29% | 6.27% | 10.09% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $18.41M | $18.41M | $16.71M |
| Total Long-Term Assets | $15.90M | $15.90M | $14.96M |
| Total Assets | $34.31M | $34.31M | $31.67M |
| YoY Change | 8.33% | 8.33% | 22.2% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $1.050M | $1.050M | $1.804M |
| YoY Change | -41.82% | -41.82% | -46.67% |
| Accrued Expenses | $794.6K | $794.6K | $555.4K |
| YoY Change | 43.09% | 43.09% | -9.55% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $34.68K |
| YoY Change | -100.0% | -100.0% | |
| Long-Term Debt Due | $490.0K | $487.0K | $308.3K |
| YoY Change | 58.96% | -11.26% | 16.25% |
| Total Short-Term Liabilities | $3.345M | $3.345M | $4.640M |
| YoY Change | -27.92% | -27.92% | -8.46% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $2.160M | $2.162M | $2.180M |
| YoY Change | -0.92% | -0.65% | 5.31% |
| Other Long-Term Liabilities | $31.77K | $3.141M | $47.42K |
| YoY Change | -33.01% | -77.07% | -92.46% |
| Total Long-Term Liabilities | $31.77K | $5.302M | $15.87M |
| YoY Change | -99.8% | -66.59% | -22.89% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $3.345M | $3.345M | $4.640M |
| Total Long-Term Liabilities | $31.77K | $5.302M | $15.87M |
| Total Liabilities | $3.377M | $8.647M | $20.51M |
| YoY Change | -83.54% | -57.84% | -20.04% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$142.7M | ||
| YoY Change | 0.48% | ||
| Common Stock | $109.8M | ||
| YoY Change | 2.13% | ||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | $306.8K | ||
| YoY Change | 0.0% | ||
| Treasury Stock Shares | 100.0K shares | 100.0K shares | |
| Shareholders Equity | $25.66M | $25.66M | -$33.12M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $34.31M | $34.31M | $31.67M |
| YoY Change | 8.32% | 8.33% | 22.2% |
Cashflow Statement
| Concept | 2017 Q1 | 2017 | 2016 Q1 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$3.186M | $3.811M | $8.499M |
| YoY Change | -137.49% | -658.0% | -233.84% |
| Depreciation, Depletion And Amortization | $210.0K | $714.5K | $180.0K |
| YoY Change | 16.67% | 7.21% | -357.14% |
| Cash From Operating Activities | -$4.070M | -$7.884M | $600.0K |
| YoY Change | -778.33% | 185.09% | -115.58% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$290.0K | -$1.105M | -$570.0K |
| YoY Change | -49.12% | -43.31% | -5.0% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $0.00 | -$120.00 | $0.00 |
| YoY Change | |||
| Cash From Investing Activities | -$290.0K | -$1.105M | -$570.0K |
| YoY Change | -49.12% | -43.3% | -5.0% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $7.593M | ||
| YoY Change | 22.48% | ||
| Debt Paid & Issued, Net | $220.0K | ||
| YoY Change | 4.76% | ||
| Cash From Financing Activities | 1.680M | $8.071M | 3.370M |
| YoY Change | -50.15% | -7.88% | -7.67% |
| NET CHANGE | |||
| Cash From Operating Activities | -4.070M | -$7.884M | 600.0K |
| Cash From Investing Activities | -290.0K | -$1.105M | -570.0K |
| Cash From Financing Activities | 1.680M | $8.071M | 3.370M |
| Net Change In Cash | -2.680M | -$917.5K | 3.400M |
| YoY Change | -178.82% | -122.67% | -525.0% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$4.070M | -$7.884M | $600.0K |
| Capital Expenditures | -$290.0K | -$1.105M | -$570.0K |
| Free Cash Flow | -$3.780M | -$6.779M | $1.170M |
| YoY Change | -423.08% | 730.16% | -136.0% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2017Q1 | us-gaap |
Assets
Assets
|
34311142 | USD |
| CY2016Q1 | us-gaap |
Assets
Assets
|
31674149 | USD |
| CY2017Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
9039404 | USD |
| CY2016Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
8110721 | USD |
| CY2017Q1 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
6419091 | USD |
| CY2016Q1 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
6411799 | USD |
| CY2017Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1049815 | USD |
| CY2016Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1804429 | USD |
| CY2017Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3344746 | USD |
| CY2017Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
794628 | USD |
| CY2016Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
555352 | USD |
| CY2017Q1 | us-gaap |
Secured Debt Current
SecuredDebtCurrent
|
70822 | USD |
| CY2016Q1 | us-gaap |
Secured Debt Current
SecuredDebtCurrent
|
205822 | USD |
| CY2017Q1 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
416148 | USD |
| CY2016Q1 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
342944 | USD |
| CY2017Q1 | us-gaap |
Secured Long Term Debt
SecuredLongTermDebt
|
1583956 | USD |
| CY2016Q1 | us-gaap |
Secured Long Term Debt
SecuredLongTermDebt
|
1654777 | USD |
| CY2017Q1 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
2265557 | USD |
| CY2016Q1 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
3278887 | USD |
| CY2017Q1 | us-gaap |
Long Term Loans Payable
LongTermLoansPayable
|
577612 | USD |
| CY2016Q1 | us-gaap |
Long Term Loans Payable
LongTermLoansPayable
|
520829 | USD |
| CY2016Q1 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
15870482 | USD |
| CY2017Q1 | us-gaap |
Security Deposit
SecurityDeposit
|
50846 | USD |
| CY2016Q1 | us-gaap |
Security Deposit
SecurityDeposit
|
48714 | USD |
| CY2016Q1 | us-gaap |
Liabilities
Liabilities
|
20510671 | USD |
| CY2016Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
711546 | USD |
| CY2016Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
109137805 | USD |
| CY2016Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-142664747 | USD |
| CY2016Q1 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
306841 | USD |
| CY2016Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-33122237 | USD |
| CY2016Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
31674149 | USD |
| CY2017Q1 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
0 | USD |
| CY2016Q1 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
44285715 | USD |
| CY2015 | us-gaap |
Revenue Other Manufactured Products
RevenueOtherManufacturedProducts
|
3870457 | USD |
| CY2015 | us-gaap |
License And Services Revenue
LicenseAndServicesRevenue
|
1139789 | USD |
| CY2015 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
5015246 | USD |
| CY2015 | us-gaap |
Operating Expenses
OperatingExpenses
|
18508626 | USD |
| CY2015 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-16506972 | USD |
| CY2015 | us-gaap |
Interest Expense
InterestExpense
|
287231 | USD |
| CY2015 | eltp |
Change In Fair Value Of Warrant Derivatives
ChangeInFairValueOfWarrantDerivatives
|
20340874 | USD |
| CY2015 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
21724328 | USD |
| CY2015 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
591214959 | shares |
| CY2015 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.02 | |
| CY2015 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.05 | |
| CY2015 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
28929674 | USD |
| CY2015 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
0 | USD |
| CY2015 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
5217356 | USD |
| CY2017 | us-gaap |
License And Services Revenue
LicenseAndServicesRevenue
|
2310756 | USD |
| CY2016 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
12498332 | USD |
| CY2016 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
4484162 | USD |
| CY2016 | us-gaap |
Gross Profit
GrossProfit
|
8014170 | USD |
| CY2017 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-7355933 | USD |
| CY2017 | us-gaap |
Net Income Loss
NetIncomeLoss
|
3811181 | USD |
| CY2016 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-683012 | USD |
| CY2017 | eltp |
Change In Value Of Convertible Preferred Share Mezzanine Equity
ChangeInValueOfConvertiblePreferredShareMezzanineEquity
|
20714286 | USD |
| CY2016 | eltp |
Change In Value Of Convertible Preferred Share Mezzanine Equity
ChangeInValueOfConvertiblePreferredShareMezzanineEquity
|
-9285715 | USD |
| CY2017 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
1943567 | USD |
| CY2016 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-1203464 | USD |
| CY2017 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
12620 | USD |
| CY2016 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
0 | USD |
| CY2016 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.01 | |
| CY2017 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
838665804 | shares |
| CY2016 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
673905485 | shares |
| CY2017 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
844506245 | shares |
| CY2016 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
673905485 | shares |
| CY2017 | us-gaap |
Interest Expense
InterestExpense
|
238223 | USD |
| CY2017 | us-gaap |
Gross Profit
GrossProfit
|
3739310 | USD |
| CY2016 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
12428783 | USD |
| CY2017 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
8301693 | USD |
| CY2016 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2903178 | USD |
| CY2017 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2083226 | USD |
| CY2016 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
333362 | USD |
| CY2017 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
357955 | USD |
| CY2016 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-8316800 | USD |
| CY2017 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
9299500 | USD |
| CY2017 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-1867614 | USD |
| CY2016 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-520452 | USD |
| CY2015 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-3249 | USD |
| CY2017 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.03 | |
| CY2015 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
260047 | USD |
| CY2015 | eltp |
Stock Issued During Period Value Execution Of Warrants
StockIssuedDuringPeriodValueExecutionOfWarrants
|
774853 | USD |
| CY2015 | eltp |
Park Capital Purchase Agreement
ParkCapitalPurchaseAgreement
|
0 | USD |
| CY2015 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
26000 | USD |
| CY2015 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
16365 | USD |
| CY2015 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
13236624 | USD |
| CY2015 | eltp |
Stock Issued During Period Value Payment Of Employee Salaries
StockIssuedDuringPeriodValuePaymentOfEmployeeSalaries
|
849737 | USD |
| CY2015 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
2272500 | USD |
| CY2017 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
714530 | USD |
| CY2016 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
666461 | USD |
| CY2017 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-9525103 | USD |
| CY2016 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-7394006 | USD |
| CY2017 | eltp |
Accrued Compensation Non Cash
AccruedCompensationNonCash
|
409750 | USD |
| CY2016 | eltp |
Accrued Compensation Non Cash
AccruedCompensationNonCash
|
573667 | USD |
| CY2017 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
357955 | USD |
| CY2016 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
333363 | USD |
| CY2017 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-596237 | USD |
| CY2016 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-33240 | USD |
| CY2017 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
3122237 | USD |
| CY2016 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
261727 | USD |
| CY2017 | eltp |
Increase Decrease In Prepaid And Other Current Assets
IncreaseDecreaseInPrepaidAndOtherCurrentAssets
|
92382 | USD |
| CY2016 | eltp |
Increase Decrease In Prepaid And Other Current Assets
IncreaseDecreaseInPrepaidAndOtherCurrentAssets
|
-160076 | USD |
| CY2016 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-2211414 | USD |
| CY2017 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
38624 | USD |
| CY2016 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
0 | USD |
| CY2017 | us-gaap |
Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
|
308834 | USD |
| CY2016 | us-gaap |
Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
|
442399 | USD |
| CY2017 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
220000 | USD |
| CY2016 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
210000 | USD |
| CY2017 | us-gaap |
Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
|
23571430 | USD |
| CY2016 | us-gaap |
Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
|
0 | USD |
| CY2017 | eltp |
Milestone Issued For Epic Strategic Alliance Agreement Value
MilestoneIssuedForEpicStrategicAllianceAgreementValue
|
0 | USD |
| CY2016 | eltp |
Milestone Issued For Epic Strategic Alliance Agreement Value
MilestoneIssuedForEpicStrategicAllianceAgreementValue
|
840000 | USD |
| CY2017 | eltp |
Increase Decrease In Deferred Revenue And Customer Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerDeposits
|
-1013330 | USD |
| CY2016 | eltp |
Increase Decrease In Deferred Revenue And Customer Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerDeposits
|
4153330 | USD |
| CY2017 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-7883861 | USD |
| CY2016 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-2765421 | USD |
| CY2017 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-1104976 | USD |
| CY2016 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-1948829 | USD |
| CY2017 | us-gaap |
Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
|
1097562 | USD |
| CY2016 | us-gaap |
Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
|
1918804 | USD |
| CY2017 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
7292 | USD |
| CY2016 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
3041499 | USD |
| CY2017 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
8071351 | USD |
| CY2016 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
8762249 | USD |
| CY2017 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-917486 | USD |
| CY2016 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
4047999 | USD |
| CY2015Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
7464180 | USD |
| CY2017 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-925088 | USD |
| CY2017 | eltp |
Commitment Shares Issued
CommitmentSharesIssued
|
69425 | USD |
| CY2016 | eltp |
Commitment Shares Issued
CommitmentSharesIssued
|
84102 | USD |
| CY2017 | eltp |
Noncash Rent Expense And Lease Accretion
NoncashRentExpenseAndLeaseAccretion
|
-17374 | USD |
| CY2016 | eltp |
Noncash Rent Expense And Lease Accretion
NoncashRentExpenseAndLeaseAccretion
|
-22996 | USD |
| CY2017 | us-gaap |
Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
|
1721 | USD |
| CY2016 | us-gaap |
Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
|
1621 | USD |
| CY2017 | us-gaap |
Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
|
0 | USD |
| CY2016 | us-gaap |
Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
|
117095 | USD |
| CY2017 | us-gaap |
Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
|
401485 | USD |
| CY2016 | us-gaap |
Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
|
404131 | USD |
| CY2015 | us-gaap |
Revenue Recognition Milestone Method Revenue Recognized
RevenueRecognitionMilestoneMethodRevenueRecognized
|
5000000 | USD |
| CY2016Q1 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
388959 | USD |
| CY2015 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-15120269 | USD |
| CY2017 | eltp |
Effect Of Dilutive Instruments On Net Income
EffectOfDilutiveInstrumentsOnNetIncome
|
30239389 | USD |
| CY2017 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
5840441 | shares |
| CY2016Q1 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
0 | USD |
| CY2016Q1 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
2845246 | USD |
| CY2016Q1 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
222784 | USD |
| CY2017Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
0 | USD |
| CY2016Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
0 | USD |
| CY2017Q1 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
0.01 | |
| CY2016Q1 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
225699 | USD |
| CY2017 | us-gaap |
Depreciation
Depreciation
|
700351 | USD |
| CY2016 | us-gaap |
Depreciation
Depreciation
|
652284 | USD |
| CY2017Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
7426752 | USD |
| CY2016Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
6726401 | USD |
| CY2016 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
95822 | USD |
| CY2017 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
87307 | USD |
| CY2017Q1 | us-gaap |
Deferred Revenue
DeferredRevenue
|
3278890 | USD |
| CY2016Q1 | us-gaap |
Deferred Revenue
DeferredRevenue
|
4292220 | USD |
| CY2015Q1 | eltp |
Warrants Outstanding
WarrantsOutstanding
|
89870034 | shares |
| CY2016Q1 | eltp |
Warrants Outstanding
WarrantsOutstanding
|
41586066 | shares |
| CY2016Q1 | eltp |
Warrants Outstanding Weighted Average Exercise Price
WarrantsOutstandingWeightedAverageExercisePrice
|
0.0625 | |
| CY2017Q1 | eltp |
Warrants Outstanding Weighted Average Exercise Price
WarrantsOutstandingWeightedAverageExercisePrice
|
0.0625 | |
| CY2017Q1 | eltp |
Warrants Outstanding
WarrantsOutstanding
|
9379219 | shares |
| CY2015Q1 | eltp |
Warrants Outstanding Weighted Average Exercise Price
WarrantsOutstandingWeightedAverageExercisePrice
|
0.0625 | |
| CY2016 | eltp |
Warrant Exercised Forfeitures And Expirations During Period
WarrantExercisedForfeituresAndExpirationsDuringPeriod
|
48283968 | shares |
| CY2017 | eltp |
Warrant Exercised Forfeitures And Expirations During Period
WarrantExercisedForfeituresAndExpirationsDuringPeriod
|
32206847 | shares |
| CY2015 | eltp |
Derivative Liability Warrants Change In Fair Value Of Warrant Liability
DerivativeLiabilityWarrantsChangeInFairValueOfWarrantLiability
|
20340874 | USD |
| CY2015Q1 | eltp |
Derivative Liability Warrants
DerivativeLiabilityWarrants
|
17762573 | USD |
| CY2017Q1 | eltp |
Common Stock Traded Percent
CommonStockTradedPercent
|
0.3 | pure |
| CY2017Q1 | eltp |
Common Stock Weighted Average Price Percent
CommonStockWeightedAveragePricePercent
|
0.97 | pure |
| CY2017 | us-gaap |
Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
|
815251 | USD |
| CY2016Q1 | us-gaap |
Due To Employees Current
DueToEmployeesCurrent
|
7500 | USD |
| CY2017 | eltp |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Grant Date Fair Value
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue
|
373055 | USD |
| CY2016 | eltp |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Grant Date Fair Value
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue
|
129913 | USD |
| CY2016 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P10Y | |
| CY2016 | eltp |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
|
0.027 | pure |
| CY2016Q1 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
0.01 | |
| CY2017Q1 | us-gaap |
Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
|
395.758 | shares |
| CY2016Q1 | us-gaap |
Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
|
495.758 | shares |
| CY2017Q1 | us-gaap |
Temporary Equity Shares Issued
TemporaryEquitySharesIssued
|
0 | shares |
| CY2016Q1 | us-gaap |
Temporary Equity Shares Issued
TemporaryEquitySharesIssued
|
100 | shares |
| CY2016Q1 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
100 | shares |
| CY2017Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2016Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2017Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
995000000 | shares |
| CY2017Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
928031448 | shares |
| CY2017Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
927931448 | shares |
| CY2016Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
711544352 | shares |
| CY2016Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
711444352 | shares |
| CY2016Q1 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
100000 | shares |
| CY2016Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
995000000 | shares |
| CY2017 | us-gaap |
Contracts Revenue
ContractsRevenue
|
0 | USD |
| CY2016 | us-gaap |
Contracts Revenue
ContractsRevenue
|
0 | USD |
| CY2015 | us-gaap |
Contracts Revenue
ContractsRevenue
|
5000 | USD |
| CY2017 | us-gaap |
Gain On Sale Of Investments
GainOnSaleOfInvestments
|
0 | USD |
| CY2016 | us-gaap |
Gain On Sale Of Investments
GainOnSaleOfInvestments
|
0 | USD |
| CY2015 | us-gaap |
Gain On Sale Of Investments
GainOnSaleOfInvestments
|
1670685 | USD |
| CY2015 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
23999 | USD |
| CY2015 | eltp |
Stock Issued During Period Value Payment Of Directors Fees
StockIssuedDuringPeriodValuePaymentOfDirectorsFees
|
110000 | USD |
| CY2016 | eltp |
Stock Issued During Period Value Execution Of Warrants
StockIssuedDuringPeriodValueExecutionOfWarrants
|
3017748 | USD |
| CY2016 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
23751 | USD |
| CY2016 | eltp |
Stock Issued During Period Value Payment Of Employee Salaries
StockIssuedDuringPeriodValuePaymentOfEmployeeSalaries
|
1039000 | USD |
| CY2016 | eltp |
Stock Issued During Period Value Payment Of Directors Fees
StockIssuedDuringPeriodValuePaymentOfDirectorsFees
|
100071 | USD |
| CY2016 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
24000 | USD |
| CY2016 | eltp |
Park Capital Purchase Agreement
ParkCapitalPurchaseAgreement
|
84102 | USD |
| CY2016 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
84102 | USD |
| CY2016 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
6199643 | USD |
| CY2016 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
333363 | USD |
| CY2016 | eltp |
Milestone Issued Value For Epic Strategic Alliance Agreement
MilestoneIssuedValueForEpicStrategicAllianceAgreement
|
840000 | USD |
| CY2017 | eltp |
Stock Issued During Period Value Execution Of Warrants
StockIssuedDuringPeriodValueExecutionOfWarrants
|
1847680 | USD |
| CY2017 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
8800 | USD |
| CY2017 | eltp |
Stock Issued During Period Value Payment Of Employee Salaries
StockIssuedDuringPeriodValuePaymentOfEmployeeSalaries
|
822751 | USD |
| CY2017 | eltp |
Stock Issued During Period Value Payment Of Directors Fees
StockIssuedDuringPeriodValuePaymentOfDirectorsFees
|
73361 | USD |
| CY2017 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
24167 | USD |
| CY2017 | eltp |
Park Capital Purchase Agreement
ParkCapitalPurchaseAgreement
|
82961 | USD |
| CY2017 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
121587 | USD |
| CY2017 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
357955 | USD |
| CY2017 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
23571430 | USD |
| CY2015 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
581855 | USD |
| CY2015 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-20340874 | USD |
| CY2015 | eltp |
Accrued Compensation Non Cash
AccruedCompensationNonCash
|
679771 | USD |
| CY2017 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
896112 | USD |
| CY2016 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
1139071 | USD |
| CY2015 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
959737 | USD |
| CY2017 | eltp |
Stock Option Plan Expense1
StockOptionPlanExpense1
|
24167 | USD |
| CY2016 | eltp |
Stock Option Plan Expense1
StockOptionPlanExpense1
|
24000 | USD |
| CY2015 | eltp |
Stock Option Plan Expense1
StockOptionPlanExpense1
|
23999 | USD |
| CY2015 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
260047 | USD |
| CY2015 | eltp |
Milestone Issued For Epic Strategic Alliance Agreement Value
MilestoneIssuedForEpicStrategicAllianceAgreementValue
|
0 | USD |
| CY2015 | eltp |
Noncash Rent Expense And Lease Accretion
NoncashRentExpenseAndLeaseAccretion
|
23703 | USD |
| CY2015 | us-gaap |
Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
|
1526 | USD |
| CY2015 | us-gaap |
Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
|
0 | USD |
| CY2015 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
714355 | USD |
| CY2015 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
1099518 | USD |
| CY2015 | eltp |
Increase Decrease In Prepaid And Other Current Assets
IncreaseDecreaseInPrepaidAndOtherCurrentAssets
|
147188 | USD |
| CY2015 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
1131477 | USD |
| CY2015 | eltp |
Increase Decrease In Deferred Revenue And Customer Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerDeposits
|
-13333 | USD |
| CY2015 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-15103233 | USD |
| CY2015 | us-gaap |
Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
|
1965018 | USD |
| CY2017 | us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
122 | USD |
| CY2016 | us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
0 | USD |
| CY2015 | us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
123916 | USD |
| CY2017 | us-gaap |
Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
|
0 | USD |
| CY2016 | us-gaap |
Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
|
0 | USD |
| CY2015 | us-gaap |
Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
|
5000000 | USD |
| CY2015 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
2879213 | USD |
| CY2015 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
800853 | USD |
| CY2015 | us-gaap |
Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
|
219010 | USD |
| CY2015 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
16365 | USD |
| CY2017 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
7593289 | USD |
| CY2016 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
6199643 | USD |
| CY2015 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
13236624 | USD |
| CY2015 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
1110000 | USD |
| CY2015 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
12746424 | USD |
| CY2015 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
522404 | USD |
| CY2014Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
6941776 | USD |
| CY2017 | us-gaap |
Interest Paid
InterestPaid
|
142351 | USD |
| CY2016 | us-gaap |
Interest Paid
InterestPaid
|
215878 | USD |
| CY2015 | us-gaap |
Interest Paid
InterestPaid
|
89336 | USD |
| CY2017 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
2500 | USD |
| CY2016 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
4048 | USD |
| CY2015 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
2500 | USD |
| CY2015 | us-gaap |
Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
|
804861 | USD |
| CY2015 | eltp |
Commitment Shares Issued
CommitmentSharesIssued
|
830521 | USD |
| CY2015 | us-gaap |
Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
|
2272500 | USD |
| CY2015 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
31853 | USD |
| CY2017 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><i><font style="FONT-SIZE: 10pt"> Reclassifications</font></i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Certain reclassifications have been made to the prior period financial statements to conform to the current period financial statement presentation. These reclassifications had no effect on net earnings or cash flows as previously reported.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2017Q1 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
389081 | USD |
| CY2017Q1 | us-gaap |
Inventory Gross
InventoryGross
|
6415966 | USD |
| CY2016Q1 | us-gaap |
Inventory Gross
InventoryGross
|
3293729 | USD |
| CY2017Q1 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
0 | USD |
| CY2016Q1 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
0 | USD |
| CY2017Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
16466156 | USD |
| CY2016Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
14837122 | USD |
| CY2017Q1 | us-gaap |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
6411799 | USD |
| CY2017 | eltp |
Intangible Assets Excluding Goodwill Acquired
IntangibleAssetsExcludingGoodwillAcquired
|
7292 | USD |
| CY2016Q1 | us-gaap |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
6381774 | USD |
| CY2016 | eltp |
Intangible Assets Excluding Goodwill Acquired
IntangibleAssetsExcludingGoodwillAcquired
|
30025 | USD |
| CY2017 | us-gaap |
Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
|
-718309 | USD |
| CY2016 | us-gaap |
Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
|
135238 | USD |
| CY2015 | us-gaap |
Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
|
54322 | USD |
| CY2014Q1 | eltp |
Derivative Liability Warrants
DerivativeLiabilityWarrants
|
38103447 | USD |
| CY2016 | eltp |
Derivative Liability Warrants Change In Fair Value Of Warrant Liability
DerivativeLiabilityWarrantsChangeInFairValueOfWarrantLiability
|
7394006 | USD |
| CY2017 | eltp |
Derivative Liability Warrants Change In Fair Value Of Warrant Liability
DerivativeLiabilityWarrantsChangeInFairValueOfWarrantLiability
|
9525103 | USD |
| CY2017 | eltp |
Conversionofseriesbseriescandseriesepreferredsharesintocommonsharesvalue
Conversionofseriesbseriescandseriesepreferredsharesintocommonsharesvalue
|
23571430 | USD |
| CY2016 | eltp |
Conversionofseriesbseriescandseriesepreferredsharesintocommonsharesvalue
Conversionofseriesbseriescandseriesepreferredsharesintocommonsharesvalue
|
0 | USD |
| CY2015 | eltp |
Conversionofseriesbseriescandseriesepreferredsharesintocommonsharesvalue
Conversionofseriesbseriescandseriesepreferredsharesintocommonsharesvalue
|
2272500 | USD |
| CY2017 | us-gaap |
Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
|
200000 | USD |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
1.2 | pure |
| CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
1.19 | pure |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
|
1.21 | pure |
| CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
|
1.2 | pure |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.015 | pure |
| CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.021 | pure |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.025 | pure |
| CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.022 | pure |
| CY2017 | us-gaap |
Revenue Recognition Milestone Method Milestone
RevenueRecognitionMilestoneMethodMilestone
|
The milestones, totaling $500k (with $405k already received), consist of amounts due upon the first shipment of each identified product, as follows: Phentermine 37.5mg tablets ($145k), Phentermine 15 &amp; 30mg capsules ($45k), Hydromorphone 8mg ($125k), Naltrexone 50mg ($95k) and the balance of $95k due in relation to the first shipment of generic products which still require marketing authorizations from the FDA, and to which there can be no assurances of such marketing authorizations being granted and accordingly there can be no assurances that the Company will earn and receive these milestone amounts. | |
| CY2017 | us-gaap |
Valuation Allowance Commentary
ValuationAllowanceCommentary
|
At March 31, 2017, 2016, and 2015 a 100% valuation allowance is provided | |
| CY2017 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | USD |
| CY2016 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | USD |
| CY2015 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | USD |
| CY2017 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
0 | USD |
| CY2016 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
0 | USD |
| CY2015 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
0 | USD |
| CY2017 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
-2500 | USD |
| CY2016 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
-4048 | USD |
| CY2015 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
3249 | USD |
| CY2017 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
0 | USD |
| CY2016 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
0 | USD |
| CY2015 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
0 | USD |
| CY2017 | us-gaap |
Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
|
1870114 | USD |
| CY2016 | us-gaap |
Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
|
524500 | USD |
| CY2015 | us-gaap |
Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
|
0 | USD |
| CY2017 | us-gaap |
Income Tax Credits And Adjustments
IncomeTaxCreditsAndAdjustments
|
1867614 | USD |
| CY2016 | us-gaap |
Income Tax Credits And Adjustments
IncomeTaxCreditsAndAdjustments
|
520452 | USD |
| CY2015 | us-gaap |
Income Tax Credits And Adjustments
IncomeTaxCreditsAndAdjustments
|
3249 | USD |
| CY2017Q1 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
29915 | USD |
| CY2016Q1 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
27033 | USD |
| CY2015Q1 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
24547 | USD |
| CY2017Q1 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
29915 | USD |
| CY2016Q1 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
27033 | USD |
| CY2015Q1 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
24547 | USD |
| CY2017Q1 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
| CY2016Q1 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
| CY2015Q1 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
| CY2017Q1 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
1350000 | USD |
| CY2016Q3 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
2686000 | USD |
| CY2016Q2 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
3271000 | USD |
| CY2016Q4 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
2331000 | USD |
| CY2017Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
172000 | USD |
| CY2016Q4 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
1727000 | USD |
| CY2016Q3 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
1851000 | USD |
| CY2016Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
2148000 | USD |
| CY2017Q1 | us-gaap |
Gross Profit
GrossProfit
|
1178000 | USD |
| CY2016Q4 | us-gaap |
Gross Profit
GrossProfit
|
604000 | USD |
| CY2016Q3 | us-gaap |
Gross Profit
GrossProfit
|
835000 | USD |
| CY2016Q2 | us-gaap |
Gross Profit
GrossProfit
|
1123000 | USD |
| CY2017Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
4368000 | USD |
| CY2016Q4 | us-gaap |
Operating Expenses
OperatingExpenses
|
2326000 | USD |
| CY2016Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
2040000 | USD |
| CY2016Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
2361000 | USD |
| CY2016Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.00 | |
| CY2016Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.03 | |
| CY2017Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.01 | |
| CY2016Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.00 | |
| CY2016Q1 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
5195000 | USD |
| CY2015Q3 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
2947000 | USD |
| CY2015Q2 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
2163000 | USD |
| CY2015Q4 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
2194000 | USD |
| CY2016Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
1036000 | USD |
| CY2015Q4 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
836000 | USD |
| CY2015Q3 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
1415000 | USD |
| CY2015Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
1197000 | USD |
| CY2016Q1 | us-gaap |
Gross Profit
GrossProfit
|
4159000 | USD |
| CY2017Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3190000 | USD |
| CY2016Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1722000 | USD |
| CY2016Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1205000 | USD |
| CY2016Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1238000 | USD |
| CY2017Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
4000 | USD |
| CY2016Q4 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
1519000 | USD |
| CY2016Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
5443000 | USD |
| CY2016Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
2334000 | USD |
| CY2017Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2016Q4 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1870000 | USD |
| CY2016Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2016Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-3000 | USD |
| CY2017Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3186000 | USD |
| CY2016Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1667000 | USD |
| CY2016Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
4238000 | USD |
| CY2016Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1099000 | USD |
| CY2017Q1 | eltp |
Change In Value Of Convertible Preferred Share Mezzanine Equity
ChangeInValueOfConvertiblePreferredShareMezzanineEquity
|
0 | USD |
| CY2016Q4 | eltp |
Change In Value Of Convertible Preferred Share Mezzanine Equity
ChangeInValueOfConvertiblePreferredShareMezzanineEquity
|
0 | USD |
| CY2016Q3 | eltp |
Change In Value Of Convertible Preferred Share Mezzanine Equity
ChangeInValueOfConvertiblePreferredShareMezzanineEquity
|
22857000 | USD |
| CY2016Q2 | eltp |
Change In Value Of Convertible Preferred Share Mezzanine Equity
ChangeInValueOfConvertiblePreferredShareMezzanineEquity
|
-2143000 | USD |
| CY2017Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-3186000 | USD |
| CY2016Q4 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
1667000 | USD |
| CY2016Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
27095000 | USD |
| CY2016Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-1044000 | USD |
| CY2017Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.03 | |
| CY2015Q4 | us-gaap |
Gross Profit
GrossProfit
|
1358000 | USD |
| CY2015Q3 | us-gaap |
Gross Profit
GrossProfit
|
1532000 | USD |
| CY2015Q2 | us-gaap |
Gross Profit
GrossProfit
|
966000 | USD |
| CY2016Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
3588000 | USD |
| CY2015Q4 | us-gaap |
Operating Expenses
OperatingExpenses
|
4071000 | USD |
| CY2015Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
5299000 | USD |
| CY2015Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
3373000 | USD |
| CY2016Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
571000 | USD |
| CY2015Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2713000 | USD |
| CY2015Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3767000 | USD |
| CY2015Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2407000 | USD |
| CY2016Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
7408000 | USD |
| CY2015Q4 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-9520000 | USD |
| CY2015Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
2086000 | USD |
| CY2015Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
7139000 | USD |
| CY2016Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-520000 | USD |
| CY2015Q4 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2015Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2015Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2016Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
8499000 | USD |
| CY2015Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-12233000 | USD |
| CY2015Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-5457000 | USD |
| CY2014Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2557000 | USD |
| CY2014Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4061000 | USD |
| CY2014Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4431000 | USD |
| CY2015Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-898000 | USD |
| CY2014Q4 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
9974000 | USD |
| CY2015Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1681000 | USD |
| CY2015Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
4732000 | USD |
| CY2016Q1 | eltp |
Change In Value Of Convertible Preferred Share Mezzanine Equity
ChangeInValueOfConvertiblePreferredShareMezzanineEquity
|
14142000 | USD |
| CY2015Q4 | eltp |
Change In Value Of Convertible Preferred Share Mezzanine Equity
ChangeInValueOfConvertiblePreferredShareMezzanineEquity
|
-24786000 | USD |
| CY2015Q3 | eltp |
Change In Value Of Convertible Preferred Share Mezzanine Equity
ChangeInValueOfConvertiblePreferredShareMezzanineEquity
|
-5071000 | USD |
| CY2015Q2 | eltp |
Change In Value Of Convertible Preferred Share Mezzanine Equity
ChangeInValueOfConvertiblePreferredShareMezzanineEquity
|
6429000 | USD |
| CY2016Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
22641000 | USD |
| CY2015Q4 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-37019000 | USD |
| CY2015Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-6753000 | USD |
| CY2015Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
11161000 | USD |
| CY2016Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.03 | |
| CY2015Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.05 | |
| CY2015Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.01 | |
| CY2015Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.02 | |
| CY2016Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.00 | |
| CY2015Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.05 | |
| CY2015Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.01 | |
| CY2015Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.00 | |
| CY2015Q1 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
1234000 | USD |
| CY2014Q4 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
1363000 | USD |
| CY2014Q3 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
1256000 | USD |
| CY2014Q2 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
1162000 | USD |
| CY2015Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
904000 | USD |
| CY2014Q4 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
700000 | USD |
| CY2014Q3 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
682000 | USD |
| CY2014Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
729000 | USD |
| CY2015Q1 | us-gaap |
Gross Profit
GrossProfit
|
331000 | USD |
| CY2014Q4 | us-gaap |
Gross Profit
GrossProfit
|
663000 | USD |
| CY2014Q3 | us-gaap |
Gross Profit
GrossProfit
|
575000 | USD |
| CY2014Q2 | us-gaap |
Gross Profit
GrossProfit
|
433000 | USD |
| CY2015Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
5788000 | USD |
| CY2014Q4 | us-gaap |
Operating Expenses
OperatingExpenses
|
3221000 | USD |
| CY2014Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
4636000 | USD |
| CY2014Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
4864000 | USD |
| CY2014Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
10310000 | USD |
| CY2014Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
2338000 | USD |
| CY2015Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-3000 | USD |
| CY2014Q4 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2014Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2014Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2015Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6350000 | USD |
| CY2014Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
7417000 | USD |
| CY2014Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
6248000 | USD |
| CY2014Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2094000 | USD |
| CY2015Q1 | eltp |
Change In Value Of Convertible Preferred Share Mezzanine Equity
ChangeInValueOfConvertiblePreferredShareMezzanineEquity
|
-2715000 | USD |
| CY2014Q4 | eltp |
Change In Value Of Convertible Preferred Share Mezzanine Equity
ChangeInValueOfConvertiblePreferredShareMezzanineEquity
|
13600000 | USD |
| CY2014Q3 | eltp |
Change In Value Of Convertible Preferred Share Mezzanine Equity
ChangeInValueOfConvertiblePreferredShareMezzanineEquity
|
15132000 | USD |
| CY2014Q2 | eltp |
Change In Value Of Convertible Preferred Share Mezzanine Equity
ChangeInValueOfConvertiblePreferredShareMezzanineEquity
|
-2308000 | USD |
| CY2015Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-9065000 | USD |
| CY2014Q4 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
21017000 | USD |
| CY2014Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
21380000 | USD |
| CY2014Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-4402000 | USD |
| CY2015Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.01 | |
| CY2014Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.03 | |
| CY2014Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.04 | |
| CY2014Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.01 | |
| CY2015Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.01 | |
| CY2014Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.01 | |
| CY2014Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.01 | |
| CY2014Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.01 | |
| CY2015 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
47828 | USD |
| CY2014Q1 | eltp |
Warrants Outstanding
WarrantsOutstanding
|
102143091 | shares |
| CY2015 | eltp |
Warrant Exercised Forfeitures And Expirations During Period
WarrantExercisedForfeituresAndExpirationsDuringPeriod
|
12273057 | shares |
| CY2014Q1 | eltp |
Warrants Outstanding Weighted Average Exercise Price
WarrantsOutstandingWeightedAverageExercisePrice
|
0.0625 | |
| CY2015 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P10Y | |
| CY2015 | eltp |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
|
0.0 | pure |
| CY2015 | eltp |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Grant Date Fair Value
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue
|
769421 | USD |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
1.2 | pure |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
|
1.21 | pure |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.022 | pure |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.028 | pure |
| CY2016Q1 | eltp |
Price Difference Between Exercise Price And Quoted Price
PriceDifferenceBetweenExercisePriceAndQuotedPrice
|
0.31 | |
| CY2015Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-34731086 | USD |
| CY2014Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-81198155 | USD |
| CY2015 | us-gaap |
Depreciation
Depreciation
|
566028 | USD |
| CY2017 | us-gaap |
Loss Contingency Disclosures
LossContingencyDisclosures
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>NOTE 10. COMMITMENTS AND CONTINGENCIES</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s consolidated financial statements. Contingencies are inherently unpredictable and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><i><font style="FONT-SIZE: 10pt">Legal Proceedings</font></i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><strong><i><font style="FONT-SIZE: 10pt">  </font></i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><i><font style="FONT-SIZE: 10pt">Arbitration with Precision Dose, Inc.</font></i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">On May 9, 2014, Precision Dose Inc., the parent company of TAGI Pharmaceuticals, Inc., commenced an arbitration against the Company alleging that the Company failed to properly supply, price and satisfy gross profit minimums regarding Phentermine 37.5mg tablets, as required by the parties’ agreements. Elite denied Precision Dose’s allegations and has counterclaimed that Precision Dose is no longer entitled to exclusivity rights with respect to Phentermine 37.5mg tablets, and is responsible for certain costs, expenses, price increases and lost profits relating to Phentermine 37.5mg tablets and the parties’ agreements. The parties have reached agreement in settlement of these issues, with Precision Dose agreeing to pay certain amounts to the Company in exchange for Elite agreeing to restore exclusivity rights with respect to Phentermine 37.5mg tablets, subject to certain defined conditions. Both parties have been complying with the agreed settlement terms and the Company has notified the Arbitrator of this settlement, requesting the issuance of proceeding termination documents.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Due to the agreements reached and adhered to with regards to this issue, the Company has determined that no contingency loss needs to be recorded.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; BACKGROUND: transparent"> <strong><i><font style="FONT-SIZE: 10pt">  </font></i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; BACKGROUND: transparent"> <strong><i><font style="FONT-SIZE: 10pt">Operating Leases – 135 Ludlow Ave.</font></i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; BACKGROUND: transparent"> <i><font style="FONT-SIZE: 10pt"> </font></i></div> <font style="FONT-SIZE: 10pt"><font style="FONT-SIZE: 10pt"></font></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; BACKGROUND: transparent" align="justify">The Company entered into an operating lease for a portion of a one-story warehouse, located at 135 Ludlow Avenue, Northvale, New Jersey (the “135 Ludlow Ave. lease”). The 135 Ludlow Ave. lease is for approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 15,000</font> square feet of floor space and began on July 1, 2010. During July 2014, the Company modified the 135 Ludlow Ave. lease in which the Company was permitted to occupy the entire <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 35,000</font> square feet of floor space in the building (“135 Ludlow Ave. modified lease”).</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; BACKGROUND: transparent" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; BACKGROUND: transparent" align="justify"><font style="FONT-SIZE: 10pt">The 135 Ludlow Ave. modified lease, includes an initial term, which expires on December 31, 2016 with two tenant renewal options of five years each, at the sole discretion of the Company. On June 22, 2016, the Company exercised the first of these renewal options, with such option including a term that begins on January 1, 2017 and expires on December 31, 2021.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; BACKGROUND: transparent" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; BACKGROUND: transparent" align="justify"><font style="FONT-SIZE: 10pt">The 135 Ludlow Ave. property required significant leasehold improvements and qualifications, as a prerequisite, for its intended future use. Manufacturing, packaging, warehousing and regulatory activities are currently conducted at this location. Additional renovations and construction to further expand the Company’s manufacturing resources are in progress.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; BACKGROUND: transparent" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <font style="FONT-SIZE: 10pt"><font style="FONT-SIZE: 10pt"></font></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; BACKGROUND: transparent" align="justify">Rent expense is recorded on the straight-line basis. Rents paid in excess is recognized as deferred rent. Rent expense under the 135 Ludlow Ave. modified lease for the years ended March 31, 2017, 2016, and 2015 was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">190,550</font>, $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">180,854</font>, and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">153,430</font>, respectively. Rent expense is recorded in general and administrative expense in the audited consolidated statements of operations. Deferred rent as of March 31, 2017 and March 31, 2016 was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,152</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">19,528</font>, respectively and recorded as a component of other long-term liabilities. <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="BACKGROUND-COLOR: transparent">The tables below shows the future minimum rental payments, exclusive of taxes, insurance and other costs, under the Ludlow Ave. lease</font>:</font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; BACKGROUND: transparent" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; BACKGROUND: transparent" align="justify"> </div> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="87%"> <div>Year ending March 31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Amount</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="87%"> <div>2018</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>212,085</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="87%"> <div>2019</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>216,321</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="87%"> <div>2020</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>220,650</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="87%"> <div>2021</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>225,063</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="87%"> <div>2022</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>229,563</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="87%"> <div>Thereafter</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,154,232</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="87%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2,257,914</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div>      <font style="FONT-SIZE: 10pt"><font style="FONT-SIZE: 10pt"></font></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; BACKGROUND: transparent" align="justify">The Company has an obligation for the restoration of its leased facility and the removal or dismantlement of certain property and equipment as a result of its business operation in accordance with ASC 410, <i>Asset Retirement and Environmental Obligations – Asset Retirement Obligations</i>. The Company records the fair value of the asset retirement obligation in the period in which it is incurred. The Company increases, annually, the liability related to this obligation. The liability is accreted to its present value each period and the capitalized cost is depreciated over the useful life of the related asset. Upon settlement of the liability, the Company records either a gain or loss. As of March 31, 2017, and March 31, 2016, the Company had a liability of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">29,616</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">27,895</font>, respectively and recorded as a component of other long-term liabilities.</div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2017Q1 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
212085 | USD |
| CY2017Q1 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
216321 | USD |
| CY2017Q1 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
220650 | USD |
| CY2017Q1 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
225063 | USD |
| CY2017Q1 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
229563 | USD |
| CY2017Q1 | us-gaap |
Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
|
1154232 | USD |
| CY2017Q1 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
2257914 | USD |
| CY2016Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.00 | |
| CY2016Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.00 | |
| CY2016Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.00 |
